Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision history updated to include a new revision v3.5.0 and remove the older v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded revision v3.4.3 to the record history and removed revision v3.4.2.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded site revision v3.4.2 to the history and removed an older funding notice and revision (v3.4.1). These edits affect display metadata rather than the trial record data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check74 days agoChange DetectedAdded a site-wide funding notice and updated the page version to v3.4.1. The previous version v3.4.0 was removed.SummaryDifference0.9%

- Check81 days agoChange DetectedUI changes add a Show glossary option, color-coded highlights for record changes, and a revision tag showing v3.4.0 (with No FEAR Act Data labeling updates). No substantive study content or functionality was altered.SummaryDifference1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.